Women having abortions are at high risk for subsequent unintended pregnancy and repeat abortion. Clearly, encouraging contraceptive use after abortion is a high priority. Long acting reversible contraceptives (LARCs, Implants and intrauterine contraception) are the most effective methods to help women avoid a repeat unwanted pregnancy and abortion. Studies in surgical abortion patients, show that "quickstart" of a LARC - i.e., inserting it during the surgical procedure - is associated with substantially greater use of that method six months later than requiring women to return later to get the device. However, today a majority of women chose medical abortion. The clinical routine is to insert LARCs at the follow up 2 to 3 weeks after the abortion treatment. Frequently women choose to do part of the abortion treatment at home and do not return for a follow up. Thus, the possibility to quick start a contraceptive method in medical abortion would be a major advantage especially if this could be done at the time of administration of mifepristone.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
NONE
Enrollment
551
Day one of medical abortion
Sahlgrenska Universitetssjukhuset/Östra
Gothenburg, Sweden
Universitetssjukhuset
Linköping, Sweden
Universitetssjukhuset i Örebro
Örebro, Sweden
Karolinska Universitetssjukhuset
Stockholm, Sweden
Danderyds Hospital
Stockholm, Sweden
Södersjukhuset
Stockholm, Sweden
Chalmers Sexual and Reproductive Health Service
Edinburgh, United Kingdom
Complete abortions without surgical intervention
Efficacy of the medical abortion treatment
Time frame: at 3 weeks follow up
Unplanned pregnancy
Numbers of pregnancies within the first year following the index abortion
Time frame: during one year FU
Number of women with complications
reports and rates of AE/SAE
Time frame: evaluated at the 3weeks FU
Rate of implant insertion
Compliance, contraceptive usage
Time frame: up to 1year FU
Bleeding
Bleeding will be evaluated with regard to both bleeding during the medical abortion and bleeding patterns during the one year FU
Time frame: Evaluated at 1 year FU
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.